N/A(healthy adults)
Conditions
Interventions
Radiating an ultrasound on measurement point (20 minutes / time
16 times).
Nonradiating an ultrasound on measurement point (20 minutes / time
16 times).
Sponsors
TES Holdings Co., Ltd.
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: [1]Healthy Japanese females aged 20-29 years. [2]Individuals who are healthy and have no chronic physical disease including skin disease. [3]Individuals whose working space is indoors. [4]Individuals whose written informed consent has been obtained. [5]Individuals who can have an examination on a designated check day. [6]Individuals judged appropriate for the study by the principal.
Exclusion criteria
Exclusion criteria: [1]Individuals using medical products. [2]Individuals with thinning hair or male pattern baldness. [3] Individuals with skin disease, such as atopic dermatitis on scalp. [4]Individuals who used a drug to treat Androgenetic Alopecia in the past 3 months. [5]Individuals who used a drug to treat a disease in the past 1 month. [6]Individuals who have a history of serious hepatopathy, kidney damage, heart disease, hematological and blood disease. [7]Individuals who contract or have a history of serious gastrointestinal disease. [8]Individuals whose BMI is over 30.0. [9]Individuals who have a habit to use a similar treatment with the test method or other hair growth promotion method. [10]Individuals who have an addiction to alcohol or a mental illness. [11]Individuals with possible changes of life style during the test period. [12]Individuals who participated in other clinical studies in the past 3 months. [13]Individuals judged inappropriate for the study by the principal.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| [1]Analysis of the number of hairs, the hair density, and the anagen:telogen ratio with TrichoScan (Week 0 and just after hair cutting, Week 0 and 3 days after hair cutting, Week 16 and just after hair cutting, Week 16 and 3 days after hair cutting). | — |
Secondary
| Measure | Time frame |
|---|---|
| *Secondary outcomes [1]Gene expression test on a hair cycle (Week 0 and just after hair cutting, Week 16 and just after hair cutting). [2]Questionnaire of physical feeling (Week 0 and just after hair cutting, Week 16 and just after hair cutting). *Safety [1]Visual examination of head by a medical doctor (Screening, Week 0 and just after hair cutting, Week 16 and just after hair cutting). [2]Doctor's questions (Screening, Week 0 and just after hair cutting, Week 16 and just after hair cutting). [2]Subject's diary (From the first day of ingestion of a test material to the last day of the test). | — |
Countries
Japan
Contacts
Public ContactRyoma Shimizu
TES Holdings Co., Ltd. Administrative Department of Clinical Trials
Outcome results
None listed